Neisseria meningitidis serogroup B recombinant lipidated factor H binding protein subfamily A - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TRUMENBA (Meningococcal group B vaccine) suspension for injection pre-filled syringe AUST R: 276920Active ingredients:
Neisseria meningitidis serogroup B recombinant lipidated factor H binding protein subfamily A
Neisseria meningitidis serogroup B recombinant lipidated factor H binding protein subfamily B
Dosage form:
Injection, suspension
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800675229
|
Deletion from market:
01 Mar 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brand available.
|